HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Psychiatry
FDA Approval
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder in Adults
FDA approves Vyvanse to treat binge eating disorder in adults.
The FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults. The recommended starting dose is 3…
The FDA has approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder in adults. It was already approved for ADHD. Th…
FDA
Apr 29, 2026
Psychiatry
FDA Approval
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder
FDA approves Vyvanse to treat binge eating disorder in adults
FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults. The approval was based on clinical stu…
The FDA approved Vyvanse for moderate to severe binge eating disorder in adults. It is a stimulant already used for ADHD. This gives patient…
FDA
Apr 29, 2026